Canada Markets close in 1 hr 14 mins

Frequency Therapeutics, Inc. (FREQ)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.9100+0.0200 (+1.06%)
As of 02:35PM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.54
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 37.8800
52 Week Low 31.0000
50-Day Moving Average 32.0302
200-Day Moving Average 32.5206

Share Statistics

Avg Vol (3 month) 3262.21k
Avg Vol (10 day) 3102.79k
Shares Outstanding 534.6M
Implied Shares Outstanding 6N/A
Float 833.77M
% Held by Insiders 17.93%
% Held by Institutions 139.02%
Shares Short (Jul 14, 2022) 4881.65k
Short Ratio (Jul 14, 2022) 41.07
Short % of Float (Jul 14, 2022) 42.73%
Short % of Shares Outstanding (Jul 14, 2022) 42.52%
Shares Short (prior month Jun 14, 2022) 41.54M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022


Profit Margin 0.00%
Operating Margin (ttm)-924.82%

Management Effectiveness

Return on Assets (ttm)-26.78%
Return on Equity (ttm)-60.47%

Income Statement

Revenue (ttm)9.42M
Revenue Per Share (ttm)0.27
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)14.07M
EBITDA -83.97M
Net Income Avi to Common (ttm)-87.7M
Diluted EPS (ttm)-2.1490
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)117.36M
Total Cash Per Share (mrq)3.36
Total Debt (mrq)45.19M
Total Debt/Equity (mrq)40.10
Current Ratio (mrq)9.85
Book Value Per Share (mrq)4.26

Cash Flow Statement

Operating Cash Flow (ttm)-67.93M
Levered Free Cash Flow (ttm)-39.09M